Prospective randomised evaluation of the proportion of diagnostic samples collected by Acquire versus ViziShot needles during Endobronchial Ultrasound Guided Lymph Node Aspiration

Dr Moayed Alawami0 个研究点目标入组 108 人开始时间: 2021年12月20日最近更新: 2021年12月27日

适应症

试验速览

暂无简介。

•All patients referred to Transbronchial Node Aspiration (TBNA) by Endoscopic Ultrasound (EBUS) that meet the following criteria:
•- Adults (defined as older than or equal to 18 years of age). There is no upper limit of age provided participants can consent.
•- Outpatient/Elective admission to perform the procedure
•- Not on anticoagulation (or withheld prior to procedure). Aspirin is ok
•- Able to consent
•- First TBNA (linear) EBUS (not a redo procedure and no linear EBUS with last 8 weeks).
•- Repeat EBUS due to participants intolerance is considered to be failure of bronchoscopy/sedation rather than failure of biopsy needle. The failed procedure results will be not be counted
•- At least 1 lymph node size greater or equal to 10 mm

•-Unable to consent, this includes but not limited to participants with dementia, intellectual difficulties, or inability to communicate.
•-Contraindication to taking biopsy – ie on anticoagulation or dual antiplatelets therapy within 48 hrs of procedure or INR > 1.5
•-Inpatients (due to being sick, likely less time to consider participation and making an informed consent). To clarify, inpatients refer to patients who were admitted via emergency department and does not include elective admission to facilitate a procedure or investigations such as who live far away from Lyell McEwin Hospital.

发起方

Dr Moayed Alawami